ArticleACR open rheumatology2024

Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial.

Filip Van den Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.